Charles Schwab Investment Management »

Ocuphire Pharma shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $159k 35k 4.55
2022-12-31 $53k 15k 3.53
2022-09-30 $31k 15k 2.08
2022-06-30 $29k 15k 1.94

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us L (FNDX)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Schwab Strategic Tr Fundamental Intl (FNDF)
Chevron Corporation (CVX)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Merck & Co (MRK)

View all positions for Charles Schwab Investment Management

Top funds holding Ocuphire Pharma

Caligan Partners
Adage Capital Partners GP
BIOS Capital Management
Balyasny Asset Management
Millennium Management
Vanguard Capital Management
Marshall Wace
Boxer Capital Management
ADAR1 Capital Management
Perceptive Advisors
Nantahala Capital Management
Woodline Partners
Boothbay Fund Management
Opaleye Management
Farallon Capital Management

View all funds holding Ocuphire Pharma